Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Bendamustine |
Security Level |
 |
Mechanism |
Bendamustine: CYP1A2 Inducers (Strong) may decrease the serum concentration of Bendamustine. Concentrations of active metabolites may be increased. |
Management |
Monitor therapy |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Bendamustine
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Bendamustine Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Bendamustine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.